Investors Research Corp’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Investors Research Corp’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7	Closed	–	–	1176
2022 Q1	$0	Hold	7	–	–	﹤0.01%	1113
2021 Q4	$0	Hold	7	–	–	﹤0.01%	1063
2021 Q3	$0	Hold	7	–	–	﹤0.01%	1048
2021 Q2	$0	Hold	7	–	–	﹤0.01%	1028
2021 Q1	$0	Buy	+7	New	+$14	﹤0.01%	1094

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Investors Research Corp's APGNW Position: Q2 2022 in Review

Investors Research Corp sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q2 2022, closing a stake of 7 shares.

Investors Research Corp first reported a position in APGNW in Q1 2021 and held it in 5 quarters. The position peaked at $0 in Q1 2022. 15 funds tracked by Wall St. Rank hold APGNW as of Q2 2022.

Investors Research Corp reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
Investors Research Corp sold 7 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q2 2022.
Investors Research Corp first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 5 quarters.
Investors Research Corp's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $0 in Q1 2022.
15 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q2 2022.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.